We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $3.89B
1-Year Est. Return 16.15%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+16.15%
3 Year Est. Return
+48.47%
5 Year Est. Return
+55.5%
10 Year Est. Return
+378.36%
AUM
$13.7B
AUM Growth
+$1.53B
Cap. Flow
+$732M
Cap. Flow %
5.35%
Top 10 Hldgs %
18.92%
Holding
125
New
6
Increased
86
Reduced
25
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 24.64%
2 Technology 20.93%
3 Industrials 14.46%
4 Financials 14.42%
5 Consumer Staples 13.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUL icon
76
H.B. Fuller
FUL
$2.74B
$83.2M 0.61%
1,612,840
+142,060
+10% +$7.04M
ENV
77
DELISTED
ENVESTNET, INC.
ENV
$81.8M 0.6%
1,175,165
+188,990
+19% +$12.3M
FRPT icon
78
Freshpet
FRPT
$3.02B
$80.5M 0.59%
1,362,770
+133,810
+11% +$7.13M
PFPT
79
DELISTED
Proofpoint, Inc.
PFPT
$77.7M 0.57%
+677,255
New +$80.7M
VRSK icon
80
Verisk Analytics
VRSK
$23.7B
$76.2M 0.56%
509,965
-169,085
-25% -$25.1M
FLO icon
81
Flowers Foods
FLO
$1.29B
$73.4M 0.54%
3,374,425
-116,225
-3% -$2.52M
CBU icon
82
Community Bank
CBU
$3.31B
$72.3M 0.53%
1,019,280
+96,390
+10% +$6.46M
SRCL
83
DELISTED
Stericycle Inc
SRCL
$72M 0.53%
1,128,435
-504,650
-31% -$29.8M
IOSP icon
84
Innospec
IOSP
$2.27B
$68.8M 0.5%
664,645
+4,250
+0.6% +$406K
MGPI icon
85
MGP Ingredients
MGPI
$309M
$68.1M 0.5%
1,406,420
+137,655
+11% +$6.45M
SXI icon
86
Standex International
SXI
$3.14B
$64.5M 0.47%
812,330
+78,550
+11% +$5.97M
BGS icon
87
B&G Foods
BGS
$256M
$59.4M 0.43%
3,312,945
+485,835
+17% +$8.17M
ELF icon
88
e.l.f. Beauty
ELF
$5.64B
$58.8M 0.43%
3,644,615
+341,285
+10% +$5.68M
EYE icon
89
National Vision
EYE
$1.27B
$56.5M 0.41%
1,741,215
+285,340
+20% +$7.85M
CVBF icon
90
CVB Financial
CVBF
$4.03B
$56M 0.41%
2,594,540
+284,905
+12% +$6.03M
BL icon
91
BlackLine
BL
$1.71B
$56M 0.41%
1,085,870
-773,595
-42% -$38.6M
ALGN icon
92
Align Technology
ALGN
$10.5B
$54.2M 0.4%
+194,235
New +$48.4M
NVST icon
93
Envista
NVST
$3.99B
$53.8M 0.39%
1,813,805
+1,413,805
+353% +$40.2M
TRS icon
94
TriMas Corp
TRS
$1.38B
$51M 0.37%
1,623,925
+523,380
+48% +$16.1M
JRVR icon
95
James River Group Holdings
JRVR
$182M
$50.6M 0.37%
1,228,220
+250,975
+26% +$9.86M
INSP icon
96
Inspire Medical Systems
INSP
$2.16B
$49.2M 0.36%
662,965
+366,575
+124% +$23.6M
ANSS
97
DELISTED
Ansys
ANSS
$46.5M 0.34%
180,505
-92,835
-34% -$22M
MORN icon
98
Morningstar
MORN
$7.63B
$46.4M 0.34%
306,695
+545
+0.2% +$83.7K
WASH icon
99
Washington Trust Bancorp
WASH
$759M
$46M 0.34%
855,050
+79,335
+10% +$4.08M
BMTC
100
DELISTED
Bryn Mawr Bank Corp
BMTC
$45.1M 0.33%
1,094,710
+131,830
+14% +$5.08M

Similar funds

Champlain Investment Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Champlain Investment Partners held 125 positions worth $13.7B, up 13% from $12.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Champlain Investment Partners deployed $732M of net new capital in Q4 2019, opening 6 new positions and adding to 86 existing holdings. Its largest new stake was Clarivate: 4,962,155 shares worth $83.4M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Splunk Inc, an estimated $65.1M trimmed.

  • Champlain Investment Partners's largest Q4 2019 buy was Clarivate: 4,962,155 shares worth $83.4M.
  • Champlain Investment Partners added most to ServiceNow in Q4 2019, an estimated $96.7M increase.
  • Champlain Investment Partners's biggest Q4 2019 reduction was Splunk Inc, cutting an estimated $65.1M.
  • Champlain Investment Partners fully exited Medidata Solutions, Inc. in Q4 2019, selling an estimated $188M.
  • Champlain Investment Partners's ten largest holdings make up 19% of its $13.7B portfolio in Q4 2019.
  • Champlain Investment Partners opened 6 new positions and closed 6 in Q4 2019.
  • Champlain Investment Partners's portfolio value rose 13% quarter-over-quarter to $13.7B.

Based on Champlain Investment Partners's 13F filing for Q4 2019, filed 13 Feb 2020.